1. Home
  2. ARRY vs VIR Comparison

ARRY vs VIR Comparison

Compare ARRY & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Array Technologies Inc.

ARRY

Array Technologies Inc.

HOLD

Current Price

$9.89

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$5.90

Market Cap

825.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARRY
VIR
Founded
1989
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
825.0M
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
ARRY
VIR
Price
$9.89
$5.90
Analyst Decision
Buy
Strong Buy
Analyst Count
20
11
Target Price
$10.38
$25.73
AVG Volume (30 Days)
5.2M
2.0M
Earning Date
11-05-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,333,329,000.00
$16,860,000.00
Revenue This Year
$40.97
N/A
Revenue Next Year
$13.09
$46.25
P/E Ratio
N/A
N/A
Revenue Growth
35.75
N/A
52 Week Low
$3.76
$4.16
52 Week High
$10.47
$14.45

Technical Indicators

Market Signals
Indicator
ARRY
VIR
Relative Strength Index (RSI) 64.00 45.29
Support Level $8.30 $5.73
Resistance Level $10.29 $6.16
Average True Range (ATR) 0.57 0.33
MACD 0.18 -0.08
Stochastic Oscillator 78.12 13.31

Price Performance

Historical Comparison
ARRY
VIR

About ARRY Array Technologies Inc.

Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's segments include: the Array legacy operating segment (Array Legacy Operations) and the STI Operations operating segment (STI Operations). It derives maximum revenue from the Array legacy operating segment. Its product is an integrated system of steel supports, electric motors, gearboxes and electronic controllers referred to as a single-axis tracker that move solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Geographically, the company's operations are in the United States, Australia, Spain, Brazil and Rest of the World with the United States deriving the majority of the revenue.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: